Taiwan
· Delayed Price · Currency is TWD ICARES Medicus Statistics
Total Valuation
ICARES Medicus has a market cap or net worth of TWD 5.26 billion. The enterprise value is 5.58 billion.
| Market Cap | 5.26B |
| Enterprise Value | 5.58B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | Jul 8, 2024 |
Share Statistics
ICARES Medicus has 42.57 million shares outstanding. The number of shares has increased by 7.40% in one year.
| Current Share Class | 42.57M |
| Shares Outstanding | 42.57M |
| Shares Change (YoY) | +7.40% |
| Shares Change (QoQ) | -0.18% |
| Owned by Insiders (%) | 18.05% |
| Owned by Institutions (%) | 0.22% |
| Float | 21.01M |
Valuation Ratios
The trailing PE ratio is 41.60.
| PE Ratio | 41.60 |
| Forward PE | n/a |
| PS Ratio | 5.28 |
| PB Ratio | 2.90 |
| P/TBV Ratio | 6.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.71, with an EV/FCF ratio of -22.50.
| EV / Earnings | 43.77 |
| EV / Sales | 5.60 |
| EV / EBITDA | 21.71 |
| EV / EBIT | 37.46 |
| EV / FCF | -22.50 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.53.
| Current Ratio | 2.22 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 3.83 |
| Debt / FCF | -3.85 |
| Interest Coverage | 6.17 |
Financial Efficiency
Return on equity (ROE) is 4.44% and return on invested capital (ROIC) is 3.81%.
| Return on Equity (ROE) | 4.44% |
| Return on Assets (ROA) | 3.45% |
| Return on Invested Capital (ROIC) | 3.81% |
| Return on Capital Employed (ROCE) | 5.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.35 |
Taxes
In the past 12 months, ICARES Medicus has paid 99.37 million in taxes.
| Income Tax | 99.37M |
| Effective Tax Rate | 55.99% |
Stock Price Statistics
The stock price has decreased by -5.00% in the last 52 weeks. The beta is 0.48, so ICARES Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -5.00% |
| 50-Day Moving Average | 114.74 |
| 200-Day Moving Average | 128.06 |
| Relative Strength Index (RSI) | 55.97 |
| Average Volume (20 Days) | 30,492 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ICARES Medicus had revenue of TWD 996.44 million and earned 127.40 million in profits. Earnings per share was 2.97.
| Revenue | 996.44M |
| Gross Profit | 640.66M |
| Operating Income | 140.61M |
| Pretax Income | 177.47M |
| Net Income | 127.40M |
| EBITDA | 214.32M |
| EBIT | 140.61M |
| Earnings Per Share (EPS) | 2.97 |
Balance Sheet
The company has 726.95 million in cash and 953.28 million in debt, giving a net cash position of -226.33 million or -5.32 per share.
| Cash & Cash Equivalents | 726.95M |
| Total Debt | 953.28M |
| Net Cash | -226.33M |
| Net Cash Per Share | -5.32 |
| Equity (Book Value) | 1.81B |
| Book Value Per Share | 40.42 |
| Working Capital | 814.09M |
Cash Flow
In the last 12 months, operating cash flow was -110.19 million and capital expenditures -137.70 million, giving a free cash flow of -247.90 million.
| Operating Cash Flow | -110.19M |
| Capital Expenditures | -137.70M |
| Free Cash Flow | -247.90M |
| FCF Per Share | -5.82 |
Margins
Gross margin is 64.29%, with operating and profit margins of 14.11% and 12.79%.
| Gross Margin | 64.29% |
| Operating Margin | 14.11% |
| Pretax Margin | 17.81% |
| Profit Margin | 12.79% |
| EBITDA Margin | 21.51% |
| EBIT Margin | 14.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.24%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.24% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.15% |
| Buyback Yield | -7.40% |
| Shareholder Yield | -7.16% |
| Earnings Yield | 2.42% |
| FCF Yield | -4.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 8, 2024. It was a forward split with a ratio of 1.1.
| Last Split Date | Jul 8, 2024 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
ICARES Medicus has an Altman Z-Score of 3.68 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.68 |
| Piotroski F-Score | 2 |